Bayer

German Stock Market Today, 2 December 2025: DAX Rebounds on Bayer Surge as Inflation Hits 2.2%

Frankfurt’s stock market turned green again on Tuesday, 2 December 2025, as the DAX 40 clawed back part of Monday’s losses, powered by a spectacular rally in Bayer and a calmer reaction than feared to fresh eurozone inflation data. Quick

2 December 2025

Bayer Stock Rockets on U.S. Roundup Breakthrough – Is the 13% Rally the Start of a Trend?

Bayer’s share price is exploding today. On 2 December 2025, the German blue chip (ISIN DE000BAY0017, ticker BAYN) is trading around €34–35 on Xetra, up roughly 13% intraday and at a fresh year high. FinanzNachrichten.de+1 The trigger: a major twist in the U.S. Roundup™ glyphosate litigation –

2 December 2025

Financial Analysis · Investment Trends · Legal News · NYSE:BAYRY · Pharmaceuticals · Stock Market

German Stock Market Today: DAX Rebounds as Bayer Surges on Stroke‑Drug Breakthrough – 24 November 2025

Germany’s stock market kicked off the new week with a relief rally on Monday, 24 November 2025 (24.11.2025). The blue‑chip DAX 40 climbed around 0.7% to close just above 23,200 points, helped by a double‑digit jump in Bayer and renewed

25 November 2025

Bayer · DAX · Financial News · NYSE:BAYRY · Pharmaceuticals · Stock Market

Bayer Aktie (BAYN) Soars Over 10% on Stroke Drug Breakthrough – All Key News for 24 November 2025

Bayer’s share price is having its strongest single session in a long time. On Monday, 24 November 2025, the Bayer Aktie (BAYN) on Xetra jumped roughly 9–11% to trade around €30–31, briefly touching a new year high near €31 and

24 November 2025

Bayer · Investing · Market Analysis · Pharma News · Stocks

DAX Today: German Stock Market Rebounds as Bayer Soars on Stroke-Drug Success — 24 November 2025

Germany’s stock market started the new week with a relief rally on Monday, 24 November 2025. The DAX 40 clawed back part of last week’s heavy losses as investors cheered a double‑digit surge in Bayer shares and looked past another weak reading on German

24 November 2025

DAX · Financial Markets · German Stocks · Market Recovery · NYSE:BAYRY · Pharmaceutical News

Bayer Q3 2025: Adjusted Profit Jumps as Company Books €934m in Litigation Charges—Guidance Intact, Shares Rise

Published: November 12, 2025 Germany’s Bayer posted a stronger‑than‑expected third quarter on Wednesday, even as it set aside additional money for U.S. glyphosate and PCB cases. The life‑sciences group kept its full‑year profit outlook, pointed to further one‑off burdens this

12 November 2025

Earnings · Financial News · Litigation · Pharmaceuticals · Stock Market